(Q44894697)

7 December 2017

1 reference

title

New Vitamin D analogues for osteodystrophy in chronic kidney disease (English)

1 reference

7 December 2017

0 references

John Cunningham

1

1 reference

7 December 2017

publication date

13 May 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

705-708

1 reference

A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice

7 December 2017

cites work

1 reference

12 December 2020

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

12 December 2020

Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2 and 1,24-dihydroxyvitamin D2 detectable in human serum

1 reference

12 December 2020

Vitamin D analogues: how do they differ and what is their clinical role?

1 reference

12 December 2020

Comparison of the relative effects of 1,24-dihydroxyvitamin D(2) [1, 24-(OH)(2)D(2)], 1,24-dihydroxyvitamin D(3) [1,24-(OH)(2)D(3)], and 1,25-dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)] on selected vitamin D-regulated events in the rat.

1 reference

12 December 2020

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

1 reference

12 December 2020

The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine

1 reference

12 December 2020

Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.

1 reference

12 December 2020

Vitamin D analogue-specific recruitment of vitamin D receptor coactivators

1 reference

12 December 2020

What is the optimal regimen for vitamin D?

1 reference

12 December 2020

Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats. Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol

1 reference

12 December 2020

Evidence for distinct membrane receptors for 1 alpha,25-(OH)(2)D(3) and 24R,25-(OH)(2)D(3) in osteoblasts

1 reference

12 December 2020

Metabolism of 22-oxacalcitriol by a vitamin D-inducible pathway in cultured parathyroid cells

1 reference

12 December 2020

Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats

1 reference

12 December 2020

The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.

1 reference

12 December 2020

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism

1 reference

12 December 2020

Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy

1 reference

12 December 2020

Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription

1 reference

12 December 2020

Effect of 22-oxacalcitriol on Secondary Hyperparathyroidism in Hemodialysis Patients

1 reference

12 December 2020

Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study

1 reference

12 December 2020

New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

A review of intravenous versus oral vitamin D hormone therapy in hemodialysis patients.

1 reference

12 December 2020

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

12 December 2020

Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2

1 reference

12 December 2020

Biochemical characterization and purification of a binding protein for 24,25-dihydroxyvitamin D3 from chick intestine

1 reference

12 December 2020

Comparative review of the pharmacokinetics of vitamin D analogues

1 reference

12 December 2020

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

1 reference

12 December 2020

1 alpha-Hydroxy-vitamin D2: a new look at an 'old' compound

1 reference

12 December 2020

A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.

1 reference

12 December 2020

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

1 reference

12 December 2020

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

12 December 2020

Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells

1 reference

12 December 2020

10.1007/S00467-004-1478-0

Identifiers

DOI

1 reference

7 December 2017

1 reference